FERMENTA BIOTECH Financial Statement Analysis
|
||
The Revenues of FERMENTA BIOTECH have decreased by -12.19% YoY .
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
FERMENTA BIOTECH Last 5 Annual Financial Results
[BOM: 506414]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹350 Cr | ₹399 Cr | ₹377 Cr | ₹293 Cr | ₹405 Cr |
Expenses | ₹332 Cr | ₹336 Cr | ₹295 Cr | ₹229 Cr | ₹269 Cr |
Operating Profit (Excl OI) | ₹18 Cr | ₹62 Cr | ₹83 Cr | ₹64 Cr | ₹135 Cr |
Other Income | ₹8.60 Cr | ₹8.25 Cr | ₹8.37 Cr | ₹14 Cr | ₹27 Cr |
Interest | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹20 Cr | ₹21 Cr |
Depreciation | ₹28 Cr | ₹26 Cr | ₹20 Cr | ₹15 Cr | ₹12 Cr |
Profit Before Tax | ₹-51 Cr | ₹27 Cr | ₹52 Cr | ₹43 Cr | ₹129 Cr |
Profit After Tax | ₹-53 Cr | ₹15 Cr | ₹43 Cr | ₹60 Cr | ₹118 Cr |
Consolidated Net Profit | ₹-51 Cr | ₹15 Cr | ₹46 Cr | ₹60 Cr | ₹117 Cr |
Earnings Per Share (Rs) | ₹-7.99 | ₹-17.70 | ₹5.35 | ₹15.77 | ₹20.63 |
PAT Margin (%) | -7.15 | -15.18 | 3.78 | 11.27 | 20.32 |
ROE(%) | -8.30 | -16.11 | 4.27 | 13.05 | 21.92 |
ROCE(%) | 1.58 | -5.25 | 7.50 | 12.62 | 12.98 |
Total Debt/Equity(x) | 0.48 | 0.72 | 0.66 | 0.66 | 0.73 |
Key Financials |
||
Market Cap | : | ₹ 960.9 Cr |
Revenue (TTM) | : | ₹ 369.5 Cr |
Net Profit(TTM) | : | ₹ 8.0 Cr |
EPS (TTM) | : | ₹ 2.7 |
P/E (TTM) | : | 119.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
FERMENTA BIOTECH | 2.4% | 6% | 105.9% |
SUN PHARMACEUTICAL INDUSTRIES | -1.4% | -7.1% | 48% |
CIPLA | -3.5% | -5.2% | 18% |
DR REDDYS LABORATORIES | -3.9% | -10.1% | 10.1% |
ZYDUS LIFESCIENCES | -0.3% | -7.3% | 52.2% |
DIVIS LABORATORIES | 1.5% | -2.1% | 63% |
MANKIND PHARMA | -2.3% | -3% | 39.6% |
TORRENT PHARMACEUTICALS | -1.8% | -10.2% | 51.3% |
LUPIN | -2.4% | -6.4% | 73.9% |
FERMENTA BIOTECH Revenues
[BOM: 506414]
Y-o-Y | -12.19 % |
5 Yr CAGR | -3.57 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹350 Cr | -12.19 | |
Mar2023 | ₹399 Cr | 5.63 | |
Mar2022 | ₹377 Cr | 28.79 | |
Mar2021 | ₹293 Cr | -27.61 | |
Mar2020 | ₹405 Cr | - |
FERMENTA BIOTECH Operating Profit
[BOM: 506414]
Y-o-Y | -70.76 % |
5 Yr CAGR | -39.44 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | -70.76 | |
Mar2023 | ₹62 Cr | -24.64 | |
Mar2022 | ₹83 Cr | 28.41 | |
Mar2021 | ₹64 Cr | -52.48 | |
Mar2020 | ₹135 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -66.71 % |
5 Yr CAGR | -37.20 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 5.2% | -66.71 | |
Mar2023 | 15.62% | -28.64 | |
Mar2022 | 21.89% | -0.27 | |
Mar2021 | 21.95% | -34.36 | |
Mar2020 | 33.44% | - |
FERMENTA BIOTECH Profit After Tax
[BOM: 506414]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-51 Cr | Negative | |
Mar2023 | ₹15 Cr | -66.06 | |
Mar2022 | ₹46 Cr | -23.55 | |
Mar2021 | ₹60 Cr | -49.32 | |
Mar2020 | ₹117 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -7.15 % | Negative | |
Mar2023 | -15.18 % | Negative | |
Mar2022 | 3.78 % | -66.46 | |
Mar2021 | 11.27 % | -44.54 | |
Mar2020 | 20.32 % | - |
FERMENTA BIOTECH Earnings Per Share (EPS)
[BOM: 506414]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹-7.99 | Negative | |
Mar2023 | ₹-18 | Negative | |
Mar2022 | ₹5.35 | -66.07 | |
Mar2021 | ₹16 | -23.56 | |
Mar2020 | ₹21 | - |
FERMENTA BIOTECH Return on Capital Employed (ROCE)
[BOM: 506414]
Y-o-Y | Positive |
5 Yr CAGR | -40.93 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 1.58% | Positive | |
Mar2023 | -5.25% | Negative | |
Mar2022 | 7.5% | -40.57 | |
Mar2021 | 12.62% | -2.77 | |
Mar2020 | 12.98% | - |
FERMENTA BIOTECH Share Price vs Sensex
Current Share Price | : | ₹326.9 |
Current MarketCap | : | ₹ 960.9 Cr |
Updated EOD on | : | Nov 21,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FERMENTA BIOTECH | 2.4% |
6% |
105.9% |
SENSEX | -1.9% |
-5% |
17.5% |
FERMENTA BIOTECH related INDICES
You may also like the below Video Courses
FAQ about FERMENTA BIOTECH Financials
How the annual revenues of FERMENTA BIOTECH have changed ?
The Revenues of FERMENTA BIOTECH have decreased by -12.19% YoY .
How the Earnings per Share (EPS) of FERMENTA BIOTECH have changed?
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs